CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$11.26
+5.14%
Mkt Cap $780.03M
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (8 analysts)
$20.00
Range $17.00 – $25.00
Implied Upside
+77.6%
Consensus $20.00 vs current $11.26
NASDAQ·Healthcare·Biotechnology
$11.26
+5.14%
Mkt Cap $780.03M
Buy
11
Hold
0
Sell
0
Price Target (8 analysts)
$20.00
Range $17.00 – $25.00
+77.6%
Consensus $20.00 vs current $11.26